Gedeon Richter
Logotype for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Gedeon Richter (RICHTER) investor relations material

Gedeon Richter Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Q3 2026 earnings summary10 Nov, 2026

Executive summary

  • Q1–Q3 Pharma revenue grew 11.7% at CER and Clean EBIT rose 25% at CER; reported revenue increased 2.6% to HUF 686.5bn amid ~9ppt FX drag.

  • Net profit rose 7.1% to HUF 174.9bn, while free cash flow reached a record HUF 223.4bn, up 12% YoY.

Financial highlights

  • Pharma gross profit, net of restructuring charges, rose 2.5% to HUF 474.5bn; gross margin eased 0.1ppt to 69.1%.

  • Pharma Clean EBIT increased 7.9% reported to HUF 229.9bn; reported EBIT rose 6.0% to HUF 216.8bn.

  • Pharma operating expenses declined 3% YoY in Q1–Q3: R&D rose 3%, S&M fell 7% and G&A increased 2%.

  • EPS rose 7.1% to HUF 956; net financial expenses remained broadly unchanged at HUF 9.5bn.

Outlook and guidance

  • FY2026 Pharma revenue growth guidance upgraded to above 10% at CER, from prior high-single-digit growth guidance.

  • FY2026 Clean EBIT growth guidance raised to the high teens at CER.

  • BIO expects further revenue growth from tocilizumab launches and additional EBIT improvement through disciplined opex; CDMO full-year CER revenue outlook increased to slight growth.

  • AbbVie raised FY2026 Vraylar net sales guidance to USD 4.2bn.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Gedeon Richter earnings date

Logotype for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Q4 20269 Feb, 2027
Gedeon Richter
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Gedeon Richter earnings date

Logotype for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Q4 20269 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. is a Hungary-based pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of a wide range of pharmaceutical products globally. The company focuses on several therapeutic areas including women's healthcare, central nervous system disorders, and cardiovascular diseases. It also offers a variety of over-the-counter products. The company is known for its commitment to providing innovative healthcare solutions and services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary, and its shares are listed on the Budapest Stock Exchange .